Get App

Co-Partners

Associate Partners

Close Ad
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Cipla

BSE: 500087|NSE: CIPLA|ISIN: INE059A01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 20, 16:00
565.60
21.65 (3.98%)
VOLUME 119,504
LIVE
NSE
May 20, 15:56
565.45
21.3 (3.91%)
VOLUME 1,586,746
Announcements on Cipla

20th-May-2019 19:39Source: BSE

Cipla- Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report20/05/2019 3 Name of the Certifying Firm BNP & Associates, Co...

17th-May-2019 20:59Source: BSE

Cipla- USFDA Post-Approval Inspection Completed At Cipla''s Indore Manufacturing Facility.

We would like to inform you that the United States Food and Drug Administration (USFDA) conducted a post-approval inspection at our Indore facility from 13th May to 17th May, 2019. The inspection ende...

17th-May-2019 18:53Source: BSE

Cipla- Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

The Operations and Administrative Committee of the Company on 17th May, 2019 has allotted 38,790 equity shares of Rs.2/- each pursuant to exercise of the stock options by the option grantees under Emp...

6th-May-2019 15:36Source: BSE

Cipla- Earnings Conference Call

We wish to inform you that, the Company will host an Earnings conference call at 1600 hrs IST (1830 hrs SST/HKT, 1130 hrs BST, 0630 hrs US ET), during which the leadership team will discuss the financ...

3rd-May-2019 09:19Source: NSE

Cipla Limited

Cipla Limited has informed the Exchange regarding ''In furtherance to the letter dated 6th March 2019 (copy enclosed), the Chief Judge Stark of the U.S. District Court of Delaware denied Amgen, Inc.??...

3rd-May-2019 09:13Source: BSE

Cipla- Announcement Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Updates

In furtherance to our letter dated 6th March 2019 (copy enclosed), we hereby inform you that Chief Judge Stark of the U.S. District Court of Delaware denied Amgen, Inc.'s request for preliminary injun...

30th-Apr-2019 08:36Source: NSE

Cipla Limited

Cipla Limited has informed the Exchange regarding a press release dated April 30, 2019, titled "Cipla receives final approval for generic version of Gilead Sciences, Inc??s Letairis?? (Ambrisentan Tab...

30th-Apr-2019 08:24Source: BSE

Cipla- Announcement under Regulation 30 (LODR)-Press Release / Media Release

We are pleased to inform you that Cipla receives final approval for generic version of Gilead Sciences, Inc''s Letairis (Ambrisentan Tabs, 5mg & 10mg)

27th-Apr-2019 14:49Source: BSE

Cipla- Announcement under Regulation 30 (LODR)-Updates on Acquisition

This is further to our letter dated 16th April 2019, we hereby notify that the Company''''s wholly owned subsidiary Cipla Medpro South Africa (Pty) Limited has completed closing of transaction and acq...

26th-Apr-2019 20:11Source: BSE

Cipla- Format of Initial Disclosure to be made by an entity identified as a Large Corporate

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayCIPLA LTD. 2CININE059A01026 3 Outstanding borrowing of company as on ...

1 2 3 4 5 Next >>
Board Meeting (Cipla)

Meeting Date

Remark

2019-05-22

Others

Quick Links for Cipla
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.